[Seite 119↓]


Akins CW, Buckley MJ, Daggett W, McIlduff JB, Austen WG. Acute traumatic disruption of the thoracic aorta: a ten-year experience. Ann Thorac Surg 1981;31:305-309.

Association Universitaire de Recherche en Chirurgie, Goëau-Brissonniere O, Doyon. Etude prospective de 597 prothèses aorto-fémorales: résultats préliminaires. Präsentiert 4e Congrès International sur la Prophylaxie des Infections , Nice, 6-7 Mai 1996.

Bach MC, Lewin EB, Sheaff ET, Schwartz L, DeBakey ME. Localization of endovascular infection by selective catheterization with serial cultures. J Thoarc Cadiovasc Surg 1975;69:377-381. url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=804076&dopt=Abstract

Bacourt F, Koskas F and the French Association for Research in Surgery. Axillobifemoral bypass and aortic exclusion for vascular septic lesions: A multicenter retrospective study of 98 cases. Ann Vasc Surg 1992;6:119-26.

Bahnini A, Plissonier D, Koskas F, Benhamour AC, Kieffer E. Traitement des infections de prothétiques aorto-iliaques par allogreffe in situ. In: Kieffer E., Goëau-Brissonnière O, Pechère JC.(Eds.); Infections artérielles, Paris, AERCV, 1997;165-176.

[Seite 120↓]

Balthazar ER, Colt JD, Nichols RL. Preoperative hair removal: a random, prospective study shaving versus clipping. South Med J 1982; 75:799-804.

Bandyk DF, Berni GA, Thiele BL, Towne JB. Aortofemoral graft infection due to Staphylococcus epidermidis . Arch Surg 1984; 119: 102-108.

Bandyk DF. Vascular graft infection. In: Bernhard VM, Towne JB . eds. Complications in Vascular Surgery, 2nd ed. Orlando,Fla.: Grune & Stratton, 1985, 471-485.

Bandyk DF. Vascular graft infections: epidemiology, microbiology, pathogenesis, and prevention. In: Bernhanrd VM, Towne JB. (eds.). Complications in Vascular Surgery. St. Louis, Quality Medical Publishing, 1991a: 223-234.

Bandyk DF, Bergamnini TM, Kinney EV, Seabrook GR, Towne JB. In situ replacement of vascular prostheses infected by bacterial biofilms. J Vasc Surg 1991b; 13:575-83.

[Seite 121↓]

Bandyk DF, Kinney EV, Riefsnyder TI, Kelly H, Twne JB. Treatment of bacteria-biofilm graft infection by in-situ replacement in normal and immune-deficient states. J Vasc Surg 1993;18:398-406.

Bandyk DF, Esses GE. Prosthetic graft infection. Surg Clin North Am 1994;74:571-590.

Barnard SP, Dark JH, Jones NAG. Prosthetic graft infection in the descending thoracic aorta treated by extra-anatomic rerouting. Cardiovasc Surg 1995; 3:703-705.

Barner HB, DeWeese JA, Dale WA, Mahoney EB. Aneurysmal degeneration of femoropopliteal arterial homografts.JAMA 1966;196:631-4.

Barner HB, De Weese JA. Aneurysmal degeneration of arterial homografts. Am Heart J 1967;73:289-291.

Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis.Thorax 1964; 19:131.

[Seite 122↓]

Barratt-Boyes BG. A method for preparing and inserting a homograft aortic valve. Br J Surg 1965;52 :847-856.

Barratt-Boyes BG. Long-term follow-up of aortic valvular grafts. Br Heart J 1971;33:60.

Baulieux J, Dureau G. Anévrysme mycotique de l’aorte thoracique rompu dans l’œsophage. Chirurgie 1982;108: 72-77.

Bergamini TM, Bandyk DF, Govostis D, Kaebnick HW, Towne JB. Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg 1988; 7: 21-30.

Bergamini TM, Bandyk DF, Govostis D, Vetsch R, Towne JB. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. J Vasc Surg 1989;9: 665-670.

Bergamini TM, Peyton MS, Cheadle WG. Prophylactic antibiotics prevent bacterial biofilm infection. J Surg Res 1992 ; 52: 101-105.

[Seite 123↓]

Bergdahl L, Ljungqvist A. Long-term results after repair of coarctation of the aorta by patch grafting. J Thorac Cardiovasc Surg 1980; 80: 177-181.

Blaisdell FW, Hall AD. Axillary-femoral artery bypass for lower extremity ischemia. Surgery 1963; 54: 563-568.

Boeckh M, Lode H, Borner K, Höffken G, Wagner J, Koeppe P. Pharmakokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers. Antimicrob Agents Chemother.1988;1 : 92-95.

Boren CH, Anthony AJ, Moore WS. Maintenance of viable arterial allografts by cryopreservation. Surgery 1977, 83 , 382-91.

Borner K, Borner E, Lode H. Bestimmung von Vancomycin mit Fluoureszenz-Polarisations-Immunoassay und der HPLC- ein Erfahrungsbericht. Labor-Medizin 1990;13:268-272.

Brown OW, Stanson AW, Pairolero PC, Hollier LH. Computerized tomography following abdominal aortic surgery. Surgery 1982;91 :716-722.

[Seite 124↓]

Bunt TJ. Synthetic vascular graft infections I. Graft infections. Surgery 1983 ; 93:733-46.

Callard GM, Wright CB, Wray RC, et al. False aneurysm due to mucor following repair of a coarctation with a Dacron prosthesis. J Thorac Cardiovasc Surg 1971;61: 181-185.

Calligaro KD, Veith FJ. Diagnosis and management of infected prosthetic aortic grafts. Surgery 1991;110: 805-813.

Callow AD. Historical overview of experimental and clinical development of vascular grafts. In: Stanley JC, ed. Biologic and synthetic vascular prostheses. New York: Grune & Stratton, 1982:11-24.

Carrel A, Guthrie CC.Uniterminal and biterminal venous transplantation. Surg Gynecol. Obstet. 1906 ; 2 :266.

Carrel A. Ultimate result of aortic transplantation. J Exp Med 1912; 15: 389-398.

[Seite 125↓]

Casey J, Flinn WR, Yao JS, Fahey V, Pawlowski J, Bergan JJ. Correlation of immune and nutritional status with wound complications in patients undergoing vascular operations. Surgery 1983;93: 822-827.

Chan FY, Crawford ES, Coselli JS, Safi HJ, Williams TW. In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg 1989;47: 193-203.

Cherry K J Jr, Roland CF, Pairolero PC, Hallett JW Jr, Meland NB, Naessens JM, Gloviczki P, Bower TC. Infected femorodistal bypass: is graft removal mandatory? J Vasc Surg 1992;15:295-305.

Chervu A, Moore WS, Chvapil M, Henderson T. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 1991a;13: 897-901.

Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prosthesis bonded with a rifampin/ collagen release system. J Vasc Surg 1991b; 14 : 521-525.

[Seite 126↓]

Chiesa, R, Astore G, Piccolo G, Melissano G, Jannello A, Frigerrio D, Agrifoglio G, Bonalumi F, Corsi G, Brancadoro SC, Novali C, Locati P, Pirrelli S, Cugnasca M, Biglioli P, Sala A, Polvaani G, Guarino A, Biasi GM, Mingazzini P, Scaalamogna M, Matero S, Spina G, Prestipino F, Sirchia G. Fresh and cyropreserved arterial homografts in the treatment of prosthetic graft infection: Experience of the italian collaborative vascular homograft group. Ann Vasc Surg 1998;12: 457-462.

Clagett GP, Bowers BL, Lopez-Viego MA, Rossi MB, Valentine RJ, Myers SI, Chervu A. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993; 218: 239-49.

Clagett GP, Valentine J, Hagino RT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability.J Vasc Surg 1997;25:255-70.

Colburn MD, Moore WS, Chvapil M, Gelabert HA, Quiñones-Baldrich WJ. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections. J Vasc Surg 1992;16 : 651-60.

Comité de l’Antibiogramme de la Société Française de Microbiologie 1994 Communiqué. Path Biol 1994;42(8):1-8.

Cooke FN, Hughes CW, Jahnke EJ, Seeley SF. Homologous arterial grafts and autogenous vein grafts. Surgery 1953; 33: 183-189.

[Seite 127↓]

Cordero JA Jr, Darling RC 3rd, Chang BB, Shah DM, Paty PS, Leather RP. In situ prosthetic graft replacement for mycotic thoracoabdominal aneurysms. Am Surg 1996;62:35-9.

Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg 1999;67:1990-93.

Crawford ES, De Bakey ME, Creech O, Cooley DA. Use of arterial homografts in 90 peripheral arterial lesions. Texas State J Med 1955 ; 51: 700-703.

Crawford ES, Creech O, Cooley DA, DE Bakey ME. Treatment of arteriosclerotic occlusive disease of the lower extremities by excision and graft replacement or bypass. Surgery 1955; 38: 981-992.

Crawford ES, Be Bakey ME. The bypass operation in the treatment of arteriosclerotic occlusive disease of the lower extremities. Surg. Gynecol. Obst. 1955; 101: 529-535.

[Seite 128↓]

Crawford ES, De Bakey ME, Morris GC, Garrett E. Evaluation of late failures after reconstructive operations for occlusive lesions of the aorta and iliac, femoral and popliteal arteries. Surgery 1960; 47, 79-101.

Crawford ES, Reardon MJ, Williams TW. Surgical considerations of infection following operations involving the descending thoracic aorta.World J Surg 1980;4:669-677.

Cruse PJE, Foord R. A five year prospective study of 23649 surgical wounds. Arch Surg 1973; 107: 206-210.

Cruse P. The epidemiology of wound infection. Surg Clin North Am 1980;60:27-40.

Curl GR, Ricotta JJ. Total prosthetic graft excision and extra-anatomic bypass. In: Calligaro KD, Veith FJ, eds. Management of infected arterial grafts . St. Louis: Quality Medical Publishing, 1994:82-94.

[Seite 129↓]

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr. Prevention of bacterial endocarditis: recommendations by the American Heart Association . Clin Infect Dis 1997 ;25:1448-58.

Davis CB Jr, Fell EH, Taylor CB. Postoperative aneurysm following surgery for coarctation of aorta. Surg Gynecol Obstet 1965 ;121: 1043-1048.

De Bakey ME, Crawford ES Crech O, Cooley DA. Arterial homografts for peripheral arteriosclerotic occlusive disease. Circulation 1957; 15: 21-30.

De Bakey ME, Crawford ES, Cooley DA, Morris GC. Surgical considerations of occlusive disease of the abdominal aorta and iliac and femoral arteries: analysis of 803 cases. Ann Surg. 1958;148: 306-324.

Desgranges P, Beujan F, Brunet S, Cavillon A, Qvarfordt P, Mellieere D, Becquemin JP. Cryopreserved arterial allografts used for treatment of infected vascular grafts. Ann Vasc Surg 1998; 12: 583-588.

[Seite 130↓]

Deterling RA. Experience with permanent bypass grafts in treatment of occlusive arterial disease. Arch Surg 1958; 76: 247-259.

Drury JK, Ashton T, Cunningham JD, Maini R, Pollock JG. Experimental and clinical experience with a gelatin impregnated Dacron prosthesis. Ann Vasc Surg 1987;1:542-547.

Dubost C, Oeconomos N, Durand M, Metianu C.Greffe d’aorte humaine conservée. Semaine des Hopitaux de Paris 1950;87: 4497-4500.

Duran CG, Gunning AJ. A method for placing a total homologous aortic valve in the subcoronary position. Lancet 1962;2: 488.

Durham JR, Rubin JR, Malone JM. Management of infected infrainguinal bypass grafts. In: Bergan JJ, YaoJST, eds. Reoperative Arterial Surgery. Philadelphia: WB Saunders, 1986, 359-373.

Eastcott HHG, Hufnagel CA. The preservation of arterial grafts by freezing. Surg. Forum. Saunders Philadelphia 1950, 269.

[Seite 131↓]

Ehrenfeld WK, Wilbur BG, Olcott CN IV, Stoney RJ. Autogenous tissue reconstruction in management of infected prosthetic grafts. Surgery 1979; 85 : 82-92.

Ernst CB, Campbell HC Jr, Daugherty ME, Sachatello CR, Griffen WO Jr. Incidence and significance of intraoperative bacterial cultures during abdominal aortic aneurysmectomy. Ann Surg 1977; 185: 626-633.

Eugène M, M'Bengue A, Bauza G, Le Moyec L, Gouezo R, Gerota J, Koskas F, Kieffer E. Method for cryopreserving human arteries: 1H NMR spectroscopy for measuring the kinetics of permeation and the ice forming tendency of cryoprotective agents (CPAs). Transplant Proc 1996;28:345.

Eugène M, Gerota J.Cryopreserved aortic allograft replacement of infected prosthetic grafts in man: processing and clinical results. Transpl Int. 1998;11:452-4.

Fabiani JN, Carpentier A, d'Allaines C, Deloche A, Bessou JP, Maazouzi W, Dubost C. Confection d’une aorte intra-thoracique droite pour la réparation chirurgicale des coarctations compliquées: à propos de 5 cas. Chirurgie 1980; 106: 400-405.

[Seite 132↓]

Favre JP, Gournier JP, Adham M, Rosset E, Barral X. Aortobronchial fistula: report of three cases and review of the literature. Surgery 1994;115:264-70.

Fiore AC, Tvey TD, Mc Keown PP, Misbach GA, Allen MD, Dillard DH. Patch closure of aortic annulus mycotic aneurysms. Ann Thorac Surg 1986 ; 42: 372-79.

Fischlein T, Schutz A, Haushofer M, Frey R, Uhlig A, Detter C, Reichart B. Immunologic reaction and viability of cryopreserved homografts. Ann Thorac Surg 1995; 60: S122-26.

Foster JH, Berzins T, Scott HW. An experimental study of arterial replacement in the presence of bacterial infection. Surg Gynecol Obstet 1959; 108: 141-148.

Fry WJ, Lindenauer SM. Infection complicating the use of plastic arterial implants. Arch Surg 1967; 94: 600-609.

Goëau-Brissonnière O, Guidoin R, Marois SM, et al. Thoracoabdominal bypass as a method of evaluating vascular grafts in the dog. Biomater Med Devices Artif Organs 1981; 9: 195-212.

[Seite 133↓]

Goëau-Brissonnière O, Leport C, Lebrault C, Renier JF, Bacourt F, Vildé JL, Pechère JC. Antibiotic prophylaxis of late bacteremic vascular graft infection in a dog model. Ann Vasc Surg 1990; 4: 528-532.

Goëau-Brissonnière O, Leport C, Bacourt F, Lebrault C, Comte R, Pechère JC. Prevention of vascular graft infection by rifampin bonding to a gelatine-sealed Dacron graft. Ann Vasc Surg 1991; 5: 408-412.

Goëau-Brissonnière O, Mercier F, Nicolas MH, Bacourt F, Coggia M, Lebrault C, Pechère JC. Treatment of vascular graft infection by in situ replacement with a rifampicin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994;19: 739-44.

Goëau-Brissonnière O, Koskas F, Pechere JC et les participants au Rifampicin Bonded Graft European Trial. Prévention des infections pariétales et prothétiques précoces: résultats du Rifampicin Bonded Graft European Trial. XII e Congrès Annuel de la Société de Chirurgie Vasculaire de Langue Française, Lyon 30. Mai-1.Juni 1996

Goldstone J, Moore WS. Infection in vascular prostheses. Am J Surg 1974;128:225-233.

[Seite 134↓]

Gooding GAW, Effeney DJ, Goldstone J. The aortofemoral graft: Detection and identification of healing complications by ultrasonography. Surgery 1981; 89 : 94-101.

Gordon LL, Hagino RT, Jackson MR, Modrall G, Valentine RJ, Clagett P. Complex aortofemoral prosthetic infections-the role of autogenous superficial femoropopliteal vein reconstruction. Arch Surg 1999;134: 615-621.

Gournier JP, Adham M, Favre JP, Raba M, Bancel B, Lepetit JC, Barral X. Cryopreserved arterial homografts: preliminary study. Ann Vasc Surg 1993 ;7:503-11.

Greco RS, Harvey RA. The role of antibiotic bonding in the prevention of vascular prosthetic infections.Ann Surg 1982; 195: 168-171.

Greisler HP, Klosak JJ, Dennis JW, Karesh SM, Ellinger J, Kim DU. Biomaterial pretreatment with ECGF to augment endothelial cell proliferation. J Vasc Surg 1987;2: 393-402.

Grinda JM, Mace L, Dervanian P, Folliguet TA, Neveux JY. Bypass graft for complex forms of isthmic aortic coarctation in adults.Ann Thorac Surg 1995; 60: 1299-1302.

Gross RE, Hurwitt ES, Bill AH, Peirce EC. Preliminary observations on the use of human arterial grafts in the treatment of certain cardiovascular defects. N Eng J Med 1948 ;239: 578-579.

Gross RE, Bill AH, Peirce EC. Methods for preservation and transplantation of arterial grafts. Surg Gynecol Obst 1949;88 : 689-701.

[Seite 135↓]

Hageman JH, Nein AG, Davis JT. Primary aortoesophageal fistula caused by an atherosclerotic thoracoabdominal aortic aneurysm: a case report and review of the literature. Cardiovasc Surg 1995; 3:495-9.

Halpert B, DeBakey ME, Jordan GL, Henley WS. The fate of homografts and prostheses of the human aorta. Surg Gynecol Obstet 1960; 111: 659-74.

Hamilton HW, Hamilton KR, Lone FJ. Preoperative hair removal. Can J Surg 1977;20: 269-71.

Hannon RJ, Wolfe JHN, Mansfield AO. Aortic prosthetic infection: 50 patients treated by radical or local surgery. Br J Surg 1996; 83: 654-658.

Harakawa I, Nakajima N, Ando M, Adachi S, Takeuchi S, Fujita T. A report of successful treatment of mediastinitis and graft infection after ascending and aortic arch reconstruction. Nippon Kyobu Geka Gakkai Zasshi 1990; 330:2112-2116.

Hargrove WC, Edmunds LH. Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg 1984; 37: 72-77.

[Seite 136↓]

Harrisson JH. Influence of infection on homografts and synthetic (TEFLON) grafts. A comparative study in experimental animals. Arch Surg 1958; 76: 67-73.

Harshman S, Boquet P, Duflot E, Alouf JE, Montcucco, Papini E. Staphylococcal alpha-toxin: A study of membrane penetration and pore formation. J Biol Chem 1989;264: 14978-14984.

Hasselgren PO, Ivarsson L, Risberg B, Seeman T. Effects of prophylactic antibiotic therapy in vascular reconstruction. Ann Surg 1984; 200: 86-92.

Haverich A, Hirt S, Karck M, Siclari F, Wahlig H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J Vasc Surg 1992;1:187-93.

Hoeksima TD, Titus JL, Giuliani ER, Kirklin JW. Early results of use of homografts for replacement of the aortic valve in man. Circulation 1967; 35/36(I):I-9.

Hoffert PW, Gensler S, Haimovici H. Infection complicating arterial grafts. Arch Surg 1965; 90:427-435.

[Seite 137↓]

Hohf RP, Trippel OH, Laufman H. Clinical comparison of homografts and braided nylon in arterial bypass surgery. Arch Surg 1958; 77: 552-559.

Hollier LH, Money SR, Creely B, Bower TC, Kazmier FJ. Direct replacement of mycotic thoracoabdominal aneurysms.J Vasc Surg 1993 ; 18: 477-485.

Humphries AW, De Wolfe VG, Lefevre FA. Major arterial grafting in one hundred sixty-nine consecutive cases. Arch Surg 1957; 74: 65-70.

Humphries AW, Hawk WA, DeWolfe VG, Lefevre FA. Clinicopathologic observations on the fate arterial freeze-dried homografts. Surgery 1959; 45: 59-69.

Jacobs MJ, Reul GJ, Gregoric I, Cooly DA. In-situ replacement and extraanatomic bypass for the treatment of infected abdominal aortic grafts. Eur J Vasc Surg 1991 ; 5: 83-86.

Jamieson GG, De Weese JA, Rob CG. Infected arterial grafts. Ann Surg 1975; 1181: 850-852.

[Seite 138↓]

Jaumin P, Bigliolo P, Stijns M, Ponlot R, Chalant CH. Le traitement de l’infection de la coarctation opérée. Ann Chir Thoarc Cardiovasc 1978; 17:129-132.

Javid H, Julian OC, Dye WS et al. Complications of aortic grafts. Arch Surg 1962 ;85 : 650-662.

Kachaner J, Fermont L, Magny JF, Villain E, Sidi D, Pedroni E, Piechaud JF. L’infection de l’anastomose: une redoutable complication des coarctations de l’aorte opérées. Arch Mal Coeur 1983; 5: 601-605.

Kaiser AB, Clayson KR, Mulherin JL. Antibiotic prophylaxis in vascular surgery. Ann Surg 1978; 188: 283-289.

Kasimir S, Schonfeld W, Alouf JE, Konig W. Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism. Infect Immun 1990; 58: 1653-1659.

Karp RB, Kirklin JW. Replacement of diseased aortic valves with homografts. Ann Surg 1969; 169: 921.

[Seite 139↓]

Kaufman SL, White RI, Harrington DP, Barth KH, Siegelman SS. Protean manifestations of mycotic aneurysms. Am J Roentgenol 1978;131:1019-1025.

Kay D, Kalmar JA. Computerized tomographic evaluation of aortic prosthetic graft complications. South Med J 1985; 78: 296-298.

Keller J, Falk J, Silberstein E, Kempczinski R. Bacterial infectibility of chronically implanted endothelial cell-seeded expanded polytertrafluoroethylene vascular grafts. J Vasc Surg 1988; 7: 524-530.

Kerwin AJ, Lenkei SC, Wilson DR. Aortic valve homograft in the treatment of aortic insufficiency: Report of nine cases with one followed for six years. N Engl J Med 1962;266 ;852.

Khatib HE, Lupinetti FM. Antigenicity of fresh and cryopreserved rat valve allografts.Transplantation 1990;49:765-67.

Kieffer E, Bahnini A, Koskas F, Ruotolo C, LeBlevec D, Plissonnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: Results in forty-three patients. J Vasc Surg 1993; 17 : 349-356.

[Seite 140↓]

Knosalla C, Weng Y, Yankah CA, Hofmeister J, Hetzer R. Using aortic allograft material to treat mycotic aneurysms of the thoracic aorta. Ann Thorac Surg 1996; 61: 1146-52.

Knosalla C, Weng Y, Warnecke H, Hummel M, Hofmeister J, Yankah CA, Hetzer R. Mycotic aortic aneurysm after orthotopic heart transplantation-A three case-report and review of the literature. J Heart Transpl 1996; 15: 827-839.

Knosalla C, Goeau-Brissonnière O, Hetzer R. Apport des modèles expérimentaux à l’étude des infections de prothèse artérielle. In: E. Kieffer, O. Goeau-Brissonnière, JP Pechère (Eds) Actualités de Chirurgie vasculaire: Infections artérielles. Editions AERCV, Paris 1997; 73-81.

Knosalla C , Weng Y,Yankah Y, Siniawski H, Hofmeister J, Hammerschmidt R, Loebe M, Hetzer R. Surgical treatment of infective aortic valve endocarditis with associated periannular abscess- 11 year results.Eur. Heart J 2000a;21:490-497.

Knosalla C, Bauer M, Weng Y, Weidemann H, Hetzer R. Complicated chronic pancreatitis causing mycotic aortic aneurysm- Treatment with a cryopreserved aortic allograft. J Vasc Surg 2000b, im Druck

[Seite 141↓]

Knox WG, Miller RE. Long-term appraisal of aortic and arterial homografts implanted in years 1954-1957. Ann Surg 1970;172: 1076-1078.

Koch L. Über Aneurysmen der Arteriae mesentericae superiores. Inaugural-abhandlung.Erlangen, J. Barfussche Universitätsdruckerei Erlangen 1851: 5-23.

Koskas F, Goëau-Brissonnière O, Nicolas MH, Bacourt F, Kieffer E. Arteries from human beings are less infectibel by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg 1996; 23: 472-76.

Krabatsch T, Hetzer R. Infected ascending aortic prosthesis: successful treatment by thoracic transposition of the greater omentum. Eur J Cardiothorac Surg 1995; 9: 223-225.

Krajicek M, Dvorak J, Chvapil M. Infection-resistant synthetic vascular substitutes. J Cardiovasc Surg 1969;10:454.

Lachapelle K, Graham AM, Symes JF. Antibacterial activity, antibiotic retention, and infection resistance of a rifampicin-impregnated gelatine-sealed Dacron graft. J Vasc Surg 1994; 19: 675-682.

[Seite 142↓]

Law MM.Bacteriology and pathogenesis of graft infection. In. Moore WS, Gelabert HA.(Eds..) Antibiotic-Impregnated Vascular grafts. Austin, RG Landes, 1992, 23-37.

Lawrence PF, Dries DJ, Alazraki N, Albo D Jr. Indium 111-labeled leucocyte scanning for detection of prosthetic vadcular graft infection. J Vasc Surg 1985; 2: 165-173.

Lehman R, West R, Leonard F. Toxicity of alkyl-2-cyanoacrylates. Arch Surg 1966; 93: 447.

Leport C, Goëau-Brissonnière O, Lebrault C, Guidoin R, Vilde JL, Bacourt F, Pechère JC. Experimental colonization of a polyester graft with Staphylococcus aureus . A quantitative and morphological study. J Vasc Surg 1988 ; 8 : 1-9.

Liekweg WG, Greenfield LJ. Vascular prosthetic infections: collected experience and results of treatment. Surgery 1977; 81: 335-342.

[Seite 143↓]

Lifschultz BD, Leestma JE, Stryker S. Multiple mycotic aneurysms and transverse myelopathy complicating repair of aortic coarctation. Ann Thorac Surg 1982; 33 : 192-196.

Linder F. Lyophilisierte Gefäßtransplantate. Langenbecks Arch. Klin Chir. 1955; 282: 655.

Liotta D, Domato FO, Bertolozzi E. Staphylococcal aortic pseudoaneurysm: treatment employing ascending aorta-abdominal aorta bypass graft. Chest 1977; 72: 243-245.

Litzler PY, Thomas P, Danielou E, Lucq J, Jacques B, Frebourg N, Plissonnier D, Bastit D, Metayer J, Peillon, Testart J, Walet J. Bacterial resistance of refrigerated and cryopreserved aortic allografts in an experimental virulent infection model. J Vasc Surg 1999; 29: 1090-1096.

Locati P, Novali C, Socrate AM, CostantiniE, Morlacchi E, Piazalungaa G, Costantini S. The use of arterial allografts in aortic graft infections-A three year experience on eighteen patients.J Cardiovasc Surg 1998;39:735-41.

[Seite 144↓]

Lorentzen JE, Nielsen OM, Arendrup H, Kimose HH, Bille S, Andersen J, Jensen CH, Jacobsen F, Roder OC. Vascular graft infection: An analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 1985; 98: 81-6.

Lorentzen JE, Nielsen OM. Aortobifemoral bypass with autogenous saphenous vein in treatment of paninfected aortic bifurcation graft. J Vasc Surg 1986;3:666-8.

Luketich JD, Sommers KE, Griffith BP, Boujoukos A, Landreneau RJ, Ferson PF, Keenan RJ. Successful management of secondary aortoesophageal fistula. Ann Thoarc Surg 1996; 62: 1852-1854.

Lyman DJ, Metcalf LC, Albo D Jr, Richards KF, Lamb J. The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. In vivo adsorption of proteins on polymer surfaces. Trans Am Soc Artif Organs 1974; 20: 474-478.

Malassiney P, Goëau-Brissonnière O, Coggia M, Pechère JC. Rifampicin loading of vascular grafts. J Antimircob Chemother 1996; 37: 1121-1129.

[Seite 145↓]

Malone J, Moore W, Campagna G, Bean B. Bacteremic infectibility of vascular grafts: The influence of pseudointimal integrity and duration of grafts function. Surgery 1975; 78: 211-216.

Marin ML, Sanchez LA, Veith FJ, Lowy FD. Experimental models of prosthetic graft infection. In: Calligaro KD, Veith FJ, eds. Management of infected arterial grafts . St. Louis : Quality Medical Publishing, 1994: 56-58.

Marrangoni AG, Cecchini LP. Homotransplantation of arterial segments preserved by the freezedrying method. Ann. Surg. 1951;134: 977.

Martin LF, Harris JM, Fehr DM, Peter AO, Appelbaum PC, Spangler SK, Thiele BL. Vascular prosthetic infection with Staphylococcus epidermidis: Experimental study of pathogenesis and therapy. J Vasc Sug 1989 ; 9: 464-71.

Martin-Paredero V, Busuttil RW, Dixon SM, Baker JD, Machleder H, Moore WS. Fate of aortic graft removal. Am J Surg 1983; 146: 194-197.

[Seite 146↓]

Mathley PJ, Beningfield SJ, Lourens S, Immelman EJ. Successful treatment of infected thoraco-abdominal aortic graft by percutaneous catheter drainage. J Vasc Surg 1991;13:513-515.

Mc Dougal EG, Burnham SJ, Johnson G. Rifampicin protection against experimental graft sepsis. J Vasc Surg 1986; 4 : 5-7.

McGriffin DC, Galbraith AJ, McLachlan GJ, Stower RE, Wong ML, Stafford EG, et al. Aortic valve infection: Risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992;104 :511-20.

McKeown PP, Miller DC, Jamieson SW, Mitchell RS, Reitz BA, Olcott C 4th, Mehigan JT, Silberstein RJ, McDougall IR. Diagnosis of arterial prosthetic graft infection by indium-111 oxine white blood cell scans. Circulation 1982; 66(I): 130-134.

Meade JW, Linton RR, Darling RC, Menedez CU. Arterial homografts. A long-term clinical follow-up. Arch Surg 1966; 93: 392-399.

[Seite 147↓]

Mestres CA, Mulet J, Pomar JL. Large-caliber cryopreserved arterial allografts in vascular reconstructive operations: Early experience. Ann Thorc Surg 1995; 60 : S105-107.

Mitchell RN, Jonas RA, Schoen FJ. Structure- function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg 1995;60: S 108-13.

Moore WS, Rosson CT, Hall AD, Thomas AN. Transient bacteremia,. A cause of infection in prosthetic vascular grafts. Am J Surg 1969; 117: 342-343.

Moore WS, Rosson CT, Hall AD. Effect of prophylactic antibiotics in preventing bacteremic infection of vascular prostheses. Surgery 1971; 69: 825-828.

Moore WS, Swanson RJ, Campagna G, Bean B. The use of fresh tissue arterial substitutes in infected fields. J Surg Res 1975;18: 229-233.

Moore WS, Cole CW. Infection in prosthetic vascular grafts. In: Moore WS (Ed.) Vascular Surgery: A Comprehensive Review. Philadelphia: WB Saunders . 1991, 598-609.

[Seite 148↓]

Moore WS. Physiopathology et classification des infections artérielles. In: Kieffer E., Goëau-Brissonnière O, Pechère JC.(Eds.); Infections artérielles, Paris , AERCV, 1997; 35-42.

Muhl E, Gatermann S, Iven H, Dendorfer A, Bruch HP. Local application of vancomycin for prophylaxix of graft infection: release of vancomycin from antibiotic-bonded dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.Ann Vasc Surg 1996;10:244-253.

Mulligan MS, Tsai TT, KneeboneJM, Ward PA, Lupinetti FM. Effects of preservation techniques on in vivo expression of adhesion molecules by aortic valve allografts. J Thorac Cardiovasc Surg 1994;107: 717-23.

Mundth ED, Darling RC, Alvarado RH, Buckley MJ, Linton RR, Austen WG. Surgical management of mycotic aneurysms and the complications of vascular reconstructive surgery. Am J Surg 1969;117: 460-470.

Murray G. Homologous aortic valve segment transplant as surgical treatment for aortic and mitral insufficiency. Angiology 1956;7: 466.

[Seite 149↓]

Myhre HO, Rein KA, Levang OW, Stenseth R, Christensen O. Surgical treatment of aneurysms of the descending thoracic aorta. Scand J Thorac Cardiovasc Surg 1987; 21: 119-121.

Najafi H, Javid H, Dye WS, Hauter JA, Julian OC. Management of infected arterial implants. Surgery 1969; 65: 539-547.

Najafi H, Javid H, Hunter et al. Descending aortic aneurysmectomy without adjuncts to avoid ischemia. Ann Thorac Surg 1980; 30: 326-335.

Nevelsteen A, Lacroix H, Suy R. Autogenous reconstructions with the lower extremity veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg 1995; 22: 129-134.

Nevelsteen A, FerynT, LacroixH,Suy R, Goffin Y. Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections. Cardiovasc Surg 1998; 6: 378-83.

Ney AL, Kelly PH, Tsukayama DT, Bubrick MP. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection. J Trauma 1990 ;30: 1000-1006.

[Seite 150↓]

O’Brien MF, Stafford EG, Gardner MAH, Pohlner PG, McGinnin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with note on chromosomal studies.J Thorac Cardiovasc Surg 1987;94:812.

O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ, Cochrane AD, Mau TK, Gall KL, Smith SE. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995; 60: 65-70.

Odagiri S, Itoh T, Yozu R, Kawada K, Inoue T. Ascending aorta-supraceliac abdominal aorta bypass: successful removal of an infected graft in the descending thoracic aorta.Chest 1979;75:722-724.

O’Hara PJ, Hertzer N, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: Review of 25- year experience. J Vasc Surg 1986;3:725-31.

Olsson P, SönderlundS, Dubiel WT, Ovenfors CO. Patch grafts or tube grafts in the repair of coartation of the aorta: a follow-up study. Scand J Thoarc Cardiovasc Sug 1976; 10:139-143.

[Seite 151↓]

Osler W. The Gulstonian lectures on malignant endocarditis. Br Med J 1885; 1: 467-470.

Oudot J.Greffe de la bifurcation aortique depuis les artères rénales jusqu’aux artères iliaques externes pour thrombose artérique. Mém. Acad. Chir. 1951;77: 642-645.

Pacifico AD, Karp RB, Kirklin JW. Homografts for replacement of the aortic valve. Circulation 1972; 45/46: I-36.

Pasic M, Carrel T, Segesser von L, Turina M.In situ repair of mycotic aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 1993;105:321-326.

Patel S, Johnston KW. Classification and management of mycotic aneurysms. Surg Gynecol Obstet 1977;144: 691-694.

Paull DE, Keagy BA. Management of aortobrochial fistula with graft replacement and omentopexy. Ann Thorac Surg 1990; 50: 972-974.

[Seite 152↓]

Pennington DG, Liberthson RR, Jacobs M, Scully H, Goldblatt A, Daggett WM. Critical review of experience with repair of coarctation of the aorta. J Thorac Cardiovasc Surg 1979; 77: 217-229.

Pipinos II, Reddy DJ. Secondary aortoesophageal fistula. J Vasc Surg 1997;26: 144-149.

Pitt HA, Postier RG, MacGowan AW, Frank LW, Surmak AJ, Sitzman JV, Bouchier-Hayes D. Prophylactic antibiotics in vascular surgery: topical, systemic or both. Ann Surg 1980;192: 356-364.

PowellTW, Burnham SJ, Johnson GA. A passive system using rifampicin to create an infection-resistant vascular prosthesis. Surgery 1983; 94: 765-769.

Prahald A, HarveyR, Greco. Diffusion of antibiotics from a polytetraethylenebezalkonium surface. Am Surg 1981; 47: 515-518.

Proctor RA. The staphylococcal fibronectin receptor: evidence for its importance in invasive infections. Rev Infect Dis 1987; 9; 335-340.

[Seite 153↓]

Quiñones-Baldrich WJ, Moore WS, Ziomek S, Chvapil M. Development of a “leak-proof” knitted Dacron prosthesis. J Vasc Surg 1986;3: 895-903.

Quiñones-Baldrich WJ, Gelabert HA. Autogenous tissue reconstruction in management of aortoiliofemoral graft infection. Ann Vasc Surg 1990;4: 223-28.

Reilly LM, Altman H, Lusby RJ, Kersh RA, Ehrenfeld WK, Stoney RJ.Late results following surgical management of vascular graft infection. J Vasc Surg 1984; 1: 36-44.

Reilly LM, Stoney RJ, Goldstone J, Ehrenfeld WK. Improved management of aortic graft infection: the influence of operation sequence and staging. J Vasc Surg 1987; 5: 421-31.

Richardson RL Jr, Pate JW, Wolf RY, Ledes C, Hopson WB Jr. The outcome of antibiotic-soaked arterial grafts in guinea pig wounds contaminated with E coli or S. aureus . J Thorac Cardiovasc Surg 1970; 59: 635-637.

[Seite 154↓]

Ricotta JJ, Faggioli GL, Stella A, Curl GR, Peer R, Upson J, D'Addato M, Anain J, Gutierrez I.Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg 1991;162:145-9.

Roesch CB, Band JW. False aneurysm due to an infected aortic anastomosis: successful resection and reanastomosis. Am J Surg 1960; 99: 90-93.

Roon AJ, Malone JM, Moore WS.Bacteremic adherence to vascular graft material and design. J Surg Res 1977; 22: 489-498.

Rosenman JE, Kempczinski RF, Berlatsky Y, PearceWH, Ramalanjaona GR, BjornsonHS. Bacterial adherence to endothelial-seeded polytetrafluoroethylene grafts. Surgery 1985; 98: 816-23.

Rosenman J, Pearce W, Kempczinski R. Bacterial adherence to vascular grafts after in vitro bacteremia. J Surg Res 1985; 38: 648-655.

Ross DN. Homograft replacement of the aortic valve. Lancet 1962; 2: 487.

[Seite 155↓]

Ross DN, Sommerville J. Correction of pulmonary atresia with a homograft aortic valve. Lancet 1966 ; 2 : 1446-1447.

Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967; 2 : 956-958.

Ross DN. Aortic root replacement with a cardiac allograft. The infected aortic root. In: Yankah, R Hetzer, DC Miller, et al. (Eds) Cardiac Valve Allografts 1962-1987 .Steinkopff Verlag Darmstadt, Springer Verlag, New York, 1988, 167.

Rokitansky CF. Handbuch der Pathologischen Anatomie. 2. Ausgabe , Braumüller’s Hofbuchandlung, Wien 1844.

Russel WL, Bard R, Krahwinkel DJ, Burns RP. A comparison of graft infectability of Dacron versus PTFE in the canine model. In: Skotnicki SH, Reinaerts H.H.M., ed. Recent Advances in Vascular Grafting. Gerrards Cross, Buckinghamshire, England: System 4 Associates, 1984:220-225.

Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988; 8: 147-153.

[Seite 156↓]

Santini C, Baiocchi P, Venditti M, Brandimarte C, Tarasi A, Rizzo L, Speziale F, Fiorani P, Serra P. Aorto-femoral graft infections: a clinical and microbiological aanlysis. J Infect 1993; 27: 17-26.

Schafer PW, Hardin CAA. The use of temporary polythene shunts to permit occlusion, resection and frozen homologous graft replacement of vital vessel segments. Surgery 1952; 31:186-199.

Schmitt DD, Bandyk DF, Pequet AJ, Towne JB. Bacterial adherence to vascular prosthesis. A determinant of graft infectivity. J Vasc Surg 1986; 3 , 732-740.

Schmitt DD, Seabrook Gr, Bandyk DF, TowneJB. Graft excision and extra-anatomic revascularization: the treatment of choice for septic aortic prosthesis. J Cardiovasc Surg 1990 ; 31: 327-32.

Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abott WM. Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988; 7: 82-92.

[Seite 157↓]

Schramel RJ, Creech O. Effects of infection and exposure on synthetic arterial prostheses. Arch Surg 1959; 78: 271-278.

Schwenzer KJ, Wang CH, Anhalt JP. Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther.Drug. Monit 1983; 5: 341-345.

Seabroock, GR. Pathobiology of Graft infections. In: Rutherford RB (Ed.), Seminars in Vascular Surgery , Saunders, Philadelphia, 1990:77-80.

Seeley SF, Hugues CW, Cook FN, Elkin DC. Traumatic arteriovenous fistulas and aneurysms in war wounded. Am J Surg 1952; 83: 471-479.

Seymour EQ. Aortooesophageal fistula as a complication of aortic prosthetic graft. Am J Roentgenol 1978; 131: 160-161.

Shah PM, Ito K, Clauss RH, Babu SC, Reynolds BM, Stahl WM. Expanded microporous polytetrafluoroethylene (PTFE) grafts in contaminated wounds: experimental and clinical study. J Trauma 1983; 23: 1030-1033.

[Seite 158↓]

Sharp WJ, Hoballah JJ, Mohan CR, Kresowik TF, Martinasevic M, Chalmers RT, Corson JD. The management of the infected aortic prosthesis: a current decade of experience. J Vasc Surg 1994;19: 844-850.

Shaw RS, Wheelock F. Blood vessel grafts in the treatment of chronic occlusive disease in the femoral artery. Surgery 1955; 37 : 94-104.

Shaw RS, Baue AE. Management of sepsis complicating arterial reconstructive surgery. Surgery 1963; 53: 75-86.

Shenk JS, Ney AL, Tsukayama DT, Olson ME, Bubrick MP.Tobramycin-adhesive in preventing and treating PTFE vascular graft infections. J Surg Res 1989;47 :487-492.

Shue WB, Worosilo SC, Donetz AP, Trooskin SZ, Harvey RA, Greco RS. Prevention of prosthetic infection with an antibiotic-bonded Dacron graft. J Vasc Surg 1988; 8: 600-605.

Shumaker HBJr, King H. Surgical management of rapidly expanding intrathoracic pulsating hematomas. Surg Gynecol Obstet 1959; 109: 155-164.

[Seite 159↓]

Singh AK, Reimer R. Subclavian flap repair after mycotic aneurysm of patch repair of coarctation. J Thorac Cardiovasc Surg 1982 ; 84: 911-916.

Siverhus DJ, Schmitt DD, Edmiston CE, Bandyk DF, Seabrook GR, Goheen MP, Towne JB. Adherence of mucin and non-mucin producing staphylococci to preclotted and albumin coated velour knitted vascular grafts. Surgery 1990; 107: 613-619.

Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human valve homografts. Ann Thorac Surg 1995; 60: 127-130.

Sobinsky KR, Flanigan DP. Antibiotic binding to polytetrafluoroethylene via glucosaminoglycan-keratin luminal coating. Surgery 1986; 100: 629-634.

Soyer R, Bessou JP, Bouchart F, Redonnet M, Mouton-Schleifer D, Arrignon. Surgical Treatment of infected composite graft after replacement of ascending aorta. Ann Thorac Surg 1994; 58: 425-428.

Sugarman B. In-vitro adherence of bacteria to prosthetic vascular grafts. Infection 1982; 10: 1-12.

[Seite 160↓]

Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993; 17: 357-370.

Svensson LG. Thoracoabdominal graft infections. In: Calligaro KD, Veith F J (Eds.) Management of infected arterial grafts. St Louis, Quality Medical Publishing, 1994: 65-81.

Svensson LG, Crawford ES. Cardiovascular and vascular disease of the aorta. Saunders, Philadelphia:, 1996:126-52.

Swan H. Aterial grafts. Surg.Gynecol.Obst.1952; 94: 115-117.

Szilagyi DE, Overhulse PR. Segmental aorto-iliac and femoral arterial occlusion. Treatment by resection and arterial graft replacement. JAMA 1955 ; 157: 426-433.

[Seite 161↓]

Szilagyi DE, Shonnard CP, Lopez JL Smyth NPD. The replacement of long and narrow arterial segments. An experimental study of heterografts and seamless woven nylon and Teflon prostheses. Surgery 1956;40: 1043-1059.

Szilagyi DE, Whitcomb JG, Smith RF. The causes of late failures in grafting therapy of peripheral occlusive arterial disease. Ann Surg 1956; 144: 611-632.

Szilagyi DE, Mc Donald RT, Smith RF, Whitecomb JG. Biologic fate of human arterial homografts. Arch Surg 1957 ; 75: 506-527.

Szilagyi DE, Rodriguez FJ, Smith RF, Elliott JP. Late fate of arterial allografts. Observation 6 to 15 years after implantation. Arch Surg 1970; 101 : 721-733.

Szilagyi DE, Smith RF, Elliott MP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972; 176: 321-333.

Taylor GW.Arterial grafting for grangrene. Ann R Coll Surg Engl 1962 ; 31 :168-186.

[Seite 162↓]

Threlkeld MG, Cobbs CG. Infectious disorders of prosthetic valves and intravascular devices. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of infectious Diseases, 3rd ed. New York:Churchill Livingstone 1990, 711-713.

Tollefson DF, Bandyk DF, Kaebnick HW, Seabrook GR, Towne JB. Surface biofilm disruption: enhanced recovery of microorganisms from vascular prostheses. Arch Surg 1987; 122: 38-43.

Torsello G, Sandmann W, Gehrt A, Jungblut RM. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results. J Vasc Surg 1993;17: 768-73.

Turnipseed WD, Berkoff HA, Detmer DE, Acher CW, Belzer FO. Arterial graft infections: Delayed vs. Immediate vascular reconstruction. Arch Surg 1983; 118: 410-414.

Uehara K, Tomisawa Y, Matsuo K, Fukuchi S, Fujiwara T, Hashimoto A. Surgical management of bleeding aortopulmonary fistula and removal of an infected graft. J Cardiovasc Surg 1983;24: 672-673.

[Seite 163↓]

Vasko JS, Raess DH, Williams TE Jr, Kakos GS, Kilman JW, Meckstroth CV, Cattaneo SM, Klassen KP. Nonpenetrating trauma to the thoracic aorta. Surgery 1977;82:400-6.

Vogt PR, von Segesser LK, Goffin Y, Niederhauser U, Genoni M, Kunzli A, Lachat M, Turina MI. Eradication of aortic infections with the use of cryopreserved arterial homografts. Ann Thorac Surg 1996; 62: 640-45.

Vogt PR, Turina MI. Management of infected aortic grafts: Development of less invasive surgery using cryopreserved homografts. Ann Thorac Surg 1999;67:1986-1989.

Vollmar JF. Rekonstruktive Chirurgie der Arterien.4. Aufl. Thieme, Stuttgart; New York ; 1996.

Volmar JF, Kogel H. Aorto-enteric fistulas as postoperative complication. J Cardiovasc, Surg. 1987; 28: 479-484.

[Seite 164↓]

Voorhees AB, Jarctski A, Blakemore AH. The use of tubes constructed from Vinyon “N” clot in bridging arterial defects. Ann Surg 1952;135: 332.

Walker WE, Cooley DA, Duncan JM, Hallman GL, Ott DA, Reul GJ. The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. Ann Surg 1987; 205: 727-32.

Warren R. Experiences with reconstructive surgery of femoral artery in arteriosclerosis obliterans.Arch Surg 1954;69: 582-593.

Warren R, Villavicencio JL. Iliofemoropopliteal arterial reconstructions for arteriosclerosis obliterans. N Engl J Med 1959 ;260: 255-263.

Weber TR, Lindenauer SM, Miller TA, Salles CA, Ramsburgh S, Gleich P. Focal infection of aortofemoral prostheses. Surgery 1976; 79: 310-312.

Weiss JP, Lorenzo FV, Campbell CD, Myerowitz RL, Webster MW. The behavior of infected arterial prostheses of expanded polytetrafluoproethylene (Gore-Tex). J Thorac Cardiovasc Surg 1977; 73: 630-636.

[Seite 165↓]

White JV, Nessel CC, Whang K. Differential effect of type of bacteria on peripheral graft infections.In: Calligaro KD, Veith FJ, eds. Management of infected arterial grafts. St. Louis: Quality Medical Publishing, 1994:25-42.

Wilson SE, Hermosillo CX, Parsa F, Gordon HE. Experimental infection of Dacron and bovine grafts. J Surg Res 1975; 18: 221-227.

Wilson SE, Wang S, Gordon HE. Perioperative antibiotic prophylaxis against vascular graft infection. Arch Surg 1977;70: 68-71.

Wilson SE, VanWagenen PB, Passaro EJ. Arterial infection. Current Prob Surg 1978;15: 85-89.

Wong RS, Champlin A, Temes RT,Wernly JA. Aortooesophageal fistula after repair of descending aortic dissection. Ann Thorac Surg 1996 ;62:588-590.

Yamamoto K, Noishiki Y, Mo M, Kondo J, Matsumoto A. Unusual inflammation responses around a collagen-impregnated vascular prosthesis. Artif Organs 1993; 17: 1010-1016.

[Seite 166↓]

Yeager RA, Moneta GL, Taylor LM , Harris EJ, McConnel DB, Porter JM. Improving surgical and limb salvage in patients with aortic graft infection. Am J Surg 1990; 159: 466-69.

Yeager RA, Porter JM. Infections artérielles et prothétiques. Ann Chir Vasc 1993; 7: 378-383.

ZILLA PM, Deutsch M, Fasol R. Endothelzellbeschichtung von Gefäßprothesen: Biologie kontra Mechanistik. In: Maurer PC, Dörrler J, v. Sommoggy S. Gefäßchirurgie im Fortschritt – Neuentwicklungen, Kontroversen, Grenzen, Perspektiven. Thieme, Stuttgart 1991, 123-135.

Zühlke,HV, HarnossBM. Septische Gefäßchirurgie,Ueberreuther, Wien 1988, S 12-23.

Zwischenberger JB, Shalaby TZ, Conti VR. Viable cryopreserved aortic homograft for aortic valve endocarditis

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: